These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 15371617)

  • 1. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake.
    Kostakoglu L; Hardoff R; Mirtcheva R; Goldsmith SJ
    Radiographics; 2004; 24(5):1411-31. PubMed ID: 15371617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake.
    Blodgett TM; Fukui MB; Snyderman CH; Branstetter BF; McCook BM; Townsend DW; Meltzer CC
    Radiographics; 2005; 25(4):897-912. PubMed ID: 16009814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.
    Shammas A; Lim R; Charron M
    Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
    Esen Akkas B; Gökaslan D; Güner L; Ilgin Karabacak N
    Rev Esp Med Nucl; 2011; 30(1):14-8. PubMed ID: 20702004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False-positive uptake on 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging.
    Culverwell AD; Scarsbrook AF; Chowdhury FU
    Clin Radiol; 2011 Apr; 66(4):366-82. PubMed ID: 21356398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
    Strunk H; Bucerius J; Jaeger U; Joe A; Flacke S; Reinhardt M; Hortling N; Palmedo H
    Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG imaging: pitfalls and artifacts.
    Abouzied MM; Crawford ES; Nabi HA
    J Nucl Med Technol; 2005 Sep; 33(3):145-55; quiz 162-3. PubMed ID: 16145222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-positive 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET/CT) scans mimicking malignancies.
    Yasar Z; Acat M; Onaran H; H Dincer E; Cetinkaya E; A Korkmaz N; Ozgül A
    Med Glas (Zenica); 2015 Feb; 12(1):40-6. PubMed ID: 25669335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET and PET-CT. State of the art and future prospects.
    Fanti S; Franchi R; Battista G; Monetti N; Canini R
    Radiol Med; 2005; 110(1-2):1-15. PubMed ID: 16163136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.
    Rosen RS; Fayad L; Wahl RL
    J Nucl Med; 2006 Aug; 47(8):1274-80. PubMed ID: 16883005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma.
    Okada M; Sato N; Ishii K; Matsumura K; Hosono M; Murakami T
    Radiographics; 2010; 30(4):939-57. PubMed ID: 20631361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bowel hot spots at PET-CT.
    Prabhakar HB; Sahani DV; Fischman AJ; Mueller PR; Blake MA
    Radiographics; 2007; 27(1):145-59. PubMed ID: 17235004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An introduction to PET-CT imaging.
    Kapoor V; McCook BM; Torok FS
    Radiographics; 2004; 24(2):523-43. PubMed ID: 15026598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology.
    Ziai P; Hayeri MR; Salei A; Salavati A; Houshmand S; Alavi A; Teytelboym OM
    Radiographics; 2016; 36(2):481-96. PubMed ID: 26963458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.